120 related articles for article (PubMed ID: 2653512)
1. Mixed chimerism after allogeneic marrow transplantation.
Frassoni F; Corvo R; Strada P; Sessarego M; Piaggio G; Figari O; Scarpati D; Bacigalupo A; Vitale V; Miceli S
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():241-3. PubMed ID: 2653512
[No Abstract] [Full Text] [Related]
2. Mixed chimerism after allogeneic marrow transplantation for leukaemia: correlation with dose of total body irradiation and graft-versus-host disease.
Frassoni F; Strada P; Sessarego M; Miceli S; Corvò R; Scarpati D; Vitale V; Piaggio G; Raffo MR; Sogno G
Bone Marrow Transplant; 1990 Apr; 5(4):235-40. PubMed ID: 2186836
[TBL] [Abstract][Full Text] [Related]
3. Mixed chimaerism; detection and significance following BMT.
McCann SR; Lawler M
Bone Marrow Transplant; 1993 Feb; 11(2):91-4. PubMed ID: 8435668
[TBL] [Abstract][Full Text] [Related]
4. Thiotepa improves allogeneic bone marrow engraftment without enhancing stem cell depletion in irradiated mice.
Down JD; Westerhof GR; Boudewijn A; Setroikromo R; Ploemacher RE
Bone Marrow Transplant; 1998 Feb; 21(4):327-30. PubMed ID: 9509964
[TBL] [Abstract][Full Text] [Related]
5. Mixed chimerism after allogeneic bone marrow transplantation for leukemias.
Bertheas MF; Lafage M; Blaise D; Stoppa AM; Viens P; Mannoni P; Maraninchi D
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():61-3. PubMed ID: 2390641
[No Abstract] [Full Text] [Related]
6. Chimerism after allogeneic hematopoietic cell transplantation in childhood acute lymphoblastic leukemia.
Ramírez M; Díaz MA; García-Sánchez F; Velasco M; Casado F; Villa M; Vicario JL; Madero L
Bone Marrow Transplant; 1996 Dec; 18(6):1161-5. PubMed ID: 8971389
[TBL] [Abstract][Full Text] [Related]
7. Total body irradiation: single dose, fractions, dose rate.
Vitale V; Scarpati D; Frassoni F; Corvó R
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():233-5. PubMed ID: 2653510
[No Abstract] [Full Text] [Related]
8. Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen.
Pelot MR; Pearson DA; Swenson K; Zhao G; Sachs J; Yang YG; Sykes M
Biol Blood Marrow Transplant; 1999; 5(3):133-43. PubMed ID: 10392959
[TBL] [Abstract][Full Text] [Related]
9. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of formation and conversion of hematopoietic mixed chimerism in nonmyeloablative allogeneic stem cell transplantation].
Ai HS; Yu CL; Wang DH; Guo M; Qiao JH; Shi BF; Sun WJ; Zhang S; Sun QY; Yao B
Zhonghua Yi Xue Za Zhi; 2003 Feb; 83(3):208-11. PubMed ID: 12812663
[TBL] [Abstract][Full Text] [Related]
11. Role of marrow microenvironment in engraftment and maintenance of allogeneic hematopoietic stem cells.
Torok-Storb B; Holmberg L
Bone Marrow Transplant; 1994; 14 Suppl 4():S71-3. PubMed ID: 7728130
[TBL] [Abstract][Full Text] [Related]
12. Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice.
Du B; Li DP; Xu KL; Pan XY
Chin Med J (Engl); 2005 Mar; 118(6):474-9. PubMed ID: 15788128
[TBL] [Abstract][Full Text] [Related]
13. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
[TBL] [Abstract][Full Text] [Related]
14. Follow-up of chimeric state during early hematopoietic reconstitution after allogeneic bone marrow transplantation using oligonucleotide probes from minisatellite gene regions.
Dörre S; Schneider EM; Haen M; Wallace RB; Wernet P
Transplant Proc; 1989 Feb; 21(1 Pt 3):3089-91. PubMed ID: 2650431
[No Abstract] [Full Text] [Related]
15. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
Gammie JS; Li S; Zeevi A; Demetris AJ; Ildstad ST; Pham SM
Circulation; 1998 Nov; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
[TBL] [Abstract][Full Text] [Related]
16. Prevention of acute graft-vs-host disease by a single low-dose cyclophosphamide injection following allogeneic bone marrow transplantation.
Prigozhina TB; Elkin G; Khitrin S; Slavin S
Exp Hematol; 2008 Dec; 36(12):1750-9. PubMed ID: 18809241
[TBL] [Abstract][Full Text] [Related]
17. Donor leukocyte transfusions and discontinuation of immunosuppressants to achieve an initial remission after allogeneic bone marrow transplantation in a patient with primary refractory acute leukemia.
Azuno Y; Kaneko T; Nishimura M; Okuya S; Nakai K; Nomiyama J; Mori K; Okafuji K; Okubo M; Matsutani A; Kamei S; Zaitsu Y; Takeuchi Y; Oka Y; Kaku K
Bone Marrow Transplant; 1996 Jul; 18(1):257-9. PubMed ID: 8832032
[TBL] [Abstract][Full Text] [Related]
18. [Allogeneic stem cell transplantation following non-myeloablative conditioning: favorable results in 21 high risk patients with hematological malignancies treated in the Utrecht University Medical Center, the Netherlands].
Petersen EJ; Lokhorst HL; Verdonck LF
Ned Tijdschr Geneeskd; 2003 Nov; 147(47):2328-32. PubMed ID: 14669540
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide.
Duerst RE; Horan JT; Liesveld JL; Abboud CN; Zwetsch LM; Senf ES; Constine LS; Raubertas RF; Passarell JA; DiPersio JF
Bone Marrow Transplant; 2000 Mar; 25(5):489-94. PubMed ID: 10713624
[TBL] [Abstract][Full Text] [Related]
20. Achieving alloengraftment without graft-versus-host disease: approaches using mixed allogeneic bone marrow transplantation.
Sykes M; Sharabi Y; Sachs DH
Bone Marrow Transplant; 1988 Sep; 3(5):379-86. PubMed ID: 3056545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
